Glass House Brands (GLAS) EBIT (QoQ) (2020 - 2026)
Glass House Brands (GLAS) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.20 Bn | 43.24 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.43 Bn | 39.78 Bn | 2.15 Bn |
| 3 | Zoetis | 32.03 Bn | 30.35 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.42 Bn | 19.76 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.05 Bn | 11.52 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - |
| 10 | Glass House Brands | 847.36 Mn | 828.81 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.13% |
| Dec 31, 2025 | -11.47% |
| Sep 30, 2025 | -206.95% |
| Dec 31, 2023 | 578.69% |
| Sep 30, 2023 | 51.63% |
| Jun 30, 2023 | -86.83% |
| Mar 31, 2023 | 48.31% |
| Dec 31, 2022 | 266.67% |
| Sep 30, 2022 | -158.14% |
| Jun 30, 2022 | 223.73% |
| Mar 31, 2022 | 30.04% |
| Dec 31, 2021 | -106.68% |
| Sep 30, 2021 | -1,062.39% |
| Jun 30, 2021 | 119.94% |
| Mar 31, 2021 | -568.98% |
| Dec 31, 2020 | 35.29% |